Walter Wenninger appointed managing director of the Health Care Sector, comprising the Pharmaceuticals, Self-Medication and Diagnostics Business Groups, effective Nov. 1. He currently is general manager of the Self-Medication Business Group. Wenninger, who has held U.S. posts with Bayer's Cutter Labs and Miles, succeeds Ernst Schraufstatter, who will begin his pre-retirement leave. Schraufstatter has been with Bayer for 39 years and has managed the Health Care Sector since 1984.
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.